2022-05-12 |
Holles Natalie C. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Prener Anne |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Symonds Jonathan |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
AFEYAN NOUBAR |
director, 10 percent owner |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Sohn Catherine A. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Rosenblatt Michael |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Cuss Francis M |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
1.24 |
31,000.00 |
|
2022-05-12 |
Epstein David R |
director |
499,762.0 |
A-Award |
A |
499,762.0 |
1.24 |
619,704.88 |
|
2022-04-21 |
Epstein David R |
director |
4,720,012.0 |
P-Purchase |
A |
30,000.0 |
1.44 |
43,329.00 |
|
2022-02-01 |
CAGNONI PABLO J |
director, officer: CEO and President |
100,000.0 |
A-Award |
D |
100,000.0 |
0.00 |
0.00 |
|
2022-02-01 |
CAGNONI PABLO J |
director, officer: CEO and President |
365,000.0 |
A-Award |
D |
365,000.0 |
6.75 |
2,463,750.00 |
|
2022-02-01 |
CAGNONI PABLO J |
director, officer: CEO and President |
63,750.0 |
M-Exempt |
D |
21,250.0 |
0.00 |
0.00 |
|
2022-02-01 |
CAGNONI PABLO J |
director, officer: CEO and President |
35,520.0 |
S-Sale |
D |
6,730.0 |
6.57 |
44,236.29 |
|
2022-02-01 |
Turka Laurence A. |
officer: Chief Scientific Officer |
34,500.0 |
A-Award |
D |
34,500.0 |
0.00 |
0.00 |
|
2022-02-01 |
Turka Laurence A. |
officer: Chief Scientific Officer |
143,750.0 |
A-Award |
D |
143,750.0 |
6.75 |
970,312.50 |
|
2022-02-01 |
Turka Laurence A. |
officer: Chief Scientific Officer |
22,312.0 |
M-Exempt |
D |
7,438.0 |
0.00 |
0.00 |
|
2022-02-01 |
Turka Laurence A. |
officer: Chief Scientific Officer |
4,921.0 |
S-Sale |
D |
2,517.0 |
6.57 |
16,544.24 |
|
2022-02-01 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
34,500.0 |
A-Award |
D |
34,500.0 |
0.00 |
0.00 |
|
2022-02-01 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
143,750.0 |
A-Award |
D |
143,750.0 |
6.75 |
970,312.50 |
|
2022-02-01 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
24,225.0 |
M-Exempt |
D |
8,075.0 |
0.00 |
0.00 |
|
2022-02-01 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
5,343.0 |
S-Sale |
D |
2,732.0 |
6.57 |
17,957.44 |
|
2022-01-31 |
Appelhans Dannielle |
officer: Chief Operating Officer |
30,000.0 |
A-Award |
A |
30,000.0 |
0.00 |
0.00 |
|
2022-01-31 |
Appelhans Dannielle |
officer: Chief Operating Officer |
125,000.0 |
A-Award |
A |
125,000.0 |
6.75 |
843,750.00 |
|
2022-01-31 |
Carmona Jose |
officer: Chief Financial Officer |
34,500.0 |
A-Award |
A |
34,500.0 |
0.00 |
0.00 |
|
2022-01-31 |
Carmona Jose |
officer: Chief Financial Officer |
143,750.0 |
A-Award |
A |
143,750.0 |
6.75 |
970,312.50 |
|
2022-01-29 |
CAGNONI PABLO J |
director, officer: CEO and President |
42,250.0 |
M-Exempt |
A |
21,250.0 |
0.00 |
0.00 |
|
2022-01-29 |
Turka Laurence A. |
officer: Chief Scientific Officer |
7,438.0 |
M-Exempt |
A |
7,438.0 |
0.00 |
0.00 |
|
2022-01-29 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
8,075.0 |
M-Exempt |
A |
8,075.0 |
0.00 |
0.00 |
|
2021-08-31 |
Appelhans Dannielle |
officer: Chief Operating Officer |
50,000.0 |
A-Award |
A |
50,000.0 |
0.00 |
0.00 |
|
2021-08-31 |
Appelhans Dannielle |
officer: Chief Operating Officer |
150,000.0 |
A-Award |
A |
150,000.0 |
21.72 |
3,258,000.00 |
|
2021-06-16 |
CAGNONI PABLO J |
director, officer: CEO and President |
29,320.0 |
G-Gift |
D |
2,200.0 |
0.00 |
0.00 |
|
2021-05-12 |
Epstein David R |
director |
27,919.0 |
A-Award |
A |
27,919.0 |
23.25 |
649,116.75 |
|
2021-05-12 |
Rosenblatt Michael |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
Sohn Catherine A. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
AFEYAN NOUBAR |
director, 10 percent owner |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
Symonds Jonathan |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
Prener Anne |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
Holles Natalie C. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-05-12 |
Cuss Francis M |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
23.25 |
581,250.00 |
|
2021-04-26 |
CAGNONI PABLO J |
director, officer: CEO and President |
31,520.0 |
G-Gift |
D |
4,000.0 |
0.00 |
0.00 |
|
2021-03-19 |
Flagship Ventures Fund IV General Partner LLC |
director, 10 percent owner |
5,859,414.0 |
P-Purchase |
A |
70,000.0 |
29.00 |
2,030,000.00 |
|
2021-03-19 |
Flagship Ventures Fund IV General Partner LLC |
director, 10 percent owner |
2,633,703.0 |
P-Purchase |
A |
70,000.0 |
29.00 |
2,030,000.00 |
|
2021-03-19 |
Flagship Ventures Fund IV General Partner LLC |
director, 10 percent owner |
15,393,593 |
P-Purchase |
A |
70,000.0 |
29.00 |
2,030,000.00 |
|
2021-03-15 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
225,000.0 |
M-Exempt |
D |
25,000.0 |
7.70 |
192,500.00 |
|
2021-03-15 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
25,000.0 |
M-Exempt |
A |
25,000.0 |
7.70 |
192,500.00 |
|
2021-03-15 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
0.0 |
S-Sale |
D |
25,000.0 |
7.70 |
192,500.00 |
|
2021-02-11 |
Epstein David R |
director |
4,690,012.0 |
S-Sale |
D |
26,704.0 |
14.93 |
398,559.87 |
|
2021-02-10 |
Epstein David R |
director |
4,716,716.0 |
S-Sale |
D |
7,404.0 |
14.79 |
109,525.15 |
|
2021-02-09 |
Epstein David R |
director |
4,724,120.0 |
S-Sale |
D |
2,100.0 |
14.83 |
31,145.94 |
|
2021-02-08 |
Epstein David R |
director |
4,726,220.0 |
S-Sale |
D |
89,233.0 |
14.88 |
1,328,117.20 |
|
2021-01-29 |
CAGNONI PABLO J |
director, officer: CEO and President |
375,000.0 |
A-Award |
A |
375,000.0 |
11.97 |
4,488,750.00 |
|
2021-01-29 |
CAGNONI PABLO J |
director, officer: CEO and President |
85,000.0 |
A-Award |
A |
85,000.0 |
0.00 |
0.00 |
|
2021-01-29 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
142,500.0 |
A-Award |
A |
142,500.0 |
11.97 |
1,705,725.00 |
|
2021-01-29 |
Coughlin Christina M. |
officer: Chief Medical Officer |
142,500.0 |
A-Award |
A |
142,500.0 |
11.97 |
1,705,725.00 |
|
2021-01-29 |
Coughlin Christina M. |
officer: Chief Medical Officer |
32,300.0 |
A-Award |
A |
32,300.0 |
0.00 |
0.00 |
|
2021-01-29 |
Turka Laurence A. |
officer: Chief Scientific Officer |
131,250.0 |
A-Award |
A |
131,250.0 |
11.97 |
1,571,062.50 |
|
2021-01-29 |
Turka Laurence A. |
officer: Chief Scientific Officer |
29,750.0 |
A-Award |
A |
29,750.0 |
0.00 |
0.00 |
|
2021-01-29 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
32,300.0 |
A-Award |
A |
32,300.0 |
0.00 |
0.00 |
|
2020-11-30 |
Carmona Jose |
officer: Chief Financial Officer |
400,000.0 |
A-Award |
A |
400,000.0 |
6.27 |
2,508,000.00 |
|
2020-05-21 |
Holles Natalie C. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-21 |
Sohn Catherine A. |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-21 |
AFEYAN NOUBAR |
director, 10 percent owner |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-21 |
Symonds Jonathan |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-21 |
Epstein David R |
director |
115,771.0 |
A-Award |
A |
115,771.0 |
6.22 |
720,095.62 |
|
2020-05-21 |
Cuss Francis M |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-21 |
Rosenblatt Michael |
director |
25,000.0 |
A-Award |
A |
25,000.0 |
6.22 |
155,500.00 |
|
2020-05-15 |
OH ANDREW M. |
officer: Chief Financial Officer |
5,000.0 |
M-Exempt |
A |
5,000.0 |
4.74 |
23,700.00 |
|
2020-05-15 |
OH ANDREW M. |
officer: Chief Financial Officer |
755,500.0 |
M-Exempt |
D |
5,000.0 |
4.74 |
23,700.00 |
|
2020-04-22 |
Coughlin Christina M. |
officer: Chief Medical Officer |
19,000.0 |
P-Purchase |
A |
19,000.0 |
5.52 |
104,813.50 |
|
2020-04-14 |
CAGNONI PABLO J |
director, officer: CEO and President |
21,000.0 |
P-Purchase |
A |
21,000.0 |
4.70 |
98,693.70 |
|
2020-03-17 |
Epstein David R |
director |
4,815,453.0 |
P-Purchase |
A |
5,000.0 |
3.76 |
18,800.00 |
|
2020-03-13 |
Epstein David R |
director |
4,805,453.0 |
P-Purchase |
A |
5,000.0 |
4.00 |
20,000.00 |
|
2020-03-13 |
Epstein David R |
director |
4,810,453.0 |
P-Purchase |
A |
5,000.0 |
4.00 |
20,000.00 |
|
2020-01-31 |
Coughlin Christina M. |
officer: Chief Medical Officer |
375,000.0 |
A-Award |
A |
375,000.0 |
7.80 |
2,925,000.00 |
|
2020-01-31 |
Turka Laurence A. |
officer: Chief Scientific Officer |
350,000.0 |
A-Award |
A |
350,000.0 |
7.80 |
2,730,000.00 |
|
2020-01-31 |
OH ANDREW M. |
officer: Chief Financial Officer |
165,000.0 |
A-Award |
A |
165,000.0 |
7.80 |
1,287,000.00 |
|
2020-01-31 |
CAGNONI PABLO J |
director, officer: CEO and President |
500,000.0 |
A-Award |
A |
500,000.0 |
7.80 |
3,900,000.00 |
|
2019-12-31 |
Prener Anne |
director |
50,000.0 |
A-Award |
A |
50,000.0 |
9.50 |
475,000.00 |
|
2019-12-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
34,843.0 |
S-Sale |
D |
48,000.0 |
2.87 |
137,760.00 |
|
2019-12-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
523,157.0 |
M-Exempt |
D |
48,000.0 |
2.87 |
137,760.00 |
|
2019-12-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
82,843.0 |
M-Exempt |
A |
48,000.0 |
2.87 |
137,760.00 |
|
2019-11-29 |
Keson-Brookes Maiken |
officer: CLO & Corp. Secretary |
250,000.0 |
A-Award |
A |
250,000.0 |
7.70 |
1,925,000.00 |
|
2019-10-14 |
LANGER ROBERT |
director |
120,000.0 |
M-Exempt |
D |
7,500.0 |
0.15 |
1,125.00 |
|
2019-10-14 |
LANGER ROBERT |
director |
7,500.0 |
M-Exempt |
A |
7,500.0 |
0.15 |
1,125.00 |
|
2019-10-14 |
LANGER ROBERT |
director |
0.0 |
S-Sale |
D |
7,500.0 |
0.15 |
1,125.00 |
|
2019-09-17 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
46,720.0 |
M-Exempt |
A |
11,877.0 |
10.05 |
119,309.22 |
|
2019-09-17 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
34,843.0 |
S-Sale |
D |
11,877.0 |
10.05 |
119,309.22 |
|
2019-09-17 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
571,157.0 |
M-Exempt |
D |
11,877.0 |
10.05 |
119,309.22 |
|
2019-09-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
70,966.0 |
M-Exempt |
A |
36,123.0 |
2.87 |
103,673.01 |
|
2019-09-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
34,843.0 |
S-Sale |
D |
36,123.0 |
2.87 |
103,673.01 |
|
2019-09-16 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
583,034.0 |
M-Exempt |
D |
36,123.0 |
2.87 |
103,673.01 |
|
2019-07-24 |
NISSEN TORBEN STRAIGHT |
officer: President |
2,052,450.0 |
M-Exempt |
A |
32,146.0 |
0.19 |
6,107.74 |
|
2019-07-24 |
NISSEN TORBEN STRAIGHT |
officer: President |
2,020,304.0 |
M-Exempt |
A |
175,000.0 |
0.18 |
31,500.00 |
|
2019-07-24 |
NISSEN TORBEN STRAIGHT |
officer: President |
175,000.0 |
M-Exempt |
D |
175,000.0 |
0.18 |
31,500.00 |
|
2019-07-24 |
NISSEN TORBEN STRAIGHT |
officer: President |
82,854.0 |
M-Exempt |
D |
32,146.0 |
0.19 |
6,107.74 |
|
2019-07-15 |
LANGER ROBERT |
director |
127,500.0 |
M-Exempt |
D |
7,500.0 |
0.15 |
1,125.00 |
|
2019-07-15 |
LANGER ROBERT |
director |
7,500.0 |
M-Exempt |
A |
7,500.0 |
0.15 |
1,125.00 |
|
2019-07-15 |
LANGER ROBERT |
director |
0.0 |
S-Sale |
D |
7,500.0 |
0.15 |
1,125.00 |
|
2019-06-20 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
35,086.0 |
M-Exempt |
A |
243.0 |
2.87 |
697.41 |
|
2019-06-20 |
CARPENTER CHRISTOPHER L. |
officer: Chief Medical Officer |
34,843.0 |
S-Sale |
D |
243.0 |
2.87 |
697.41 |
|